Abstract
The pharmaceutical industry is one of the most innovative sectors in the world. In 2014, the global drug sales market exceeded one trillion dollars for the first time. Innovative, patented drugs represent the largest part of pharmaceutical sales revenues. Nowadays partnerships, licensing and M&A are important parts of R&D strategies to use assets in the most efficient way and accelerate translation of biomedical innovations to bring novel products, services and solutions to the market for patients who need them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
